| Transient protein–protein interactions SE Acuner Ozbabacan, HB Engin, A Gursoy, O Keskin Protein engineering, design and selection 24 (9), 635-648, 2011 | 283 | 2011 |
| MHC-I genotype restricts the oncogenic mutational landscape R Marty, S Kaabinejadian, D Rossell, MJ Slifker, J van de Haar, HB Engin, ... Cell 171 (6), 1272-1283. e15, 2017 | 232 | 2017 |
| Hot spots in protein–protein interfaces: Towards drug discovery E Cukuroglu, HB Engin, A Gursoy, O Keskin Progress in biophysics and molecular biology 116 (2-3), 165-173, 2014 | 147 | 2014 |
| Structure-based analysis reveals cancer missense mutations target protein interaction interfaces HB Engin, JF Kreisberg, H Carter PloS one 11 (4), e0152929, 2016 | 77 | 2016 |
| The structural network of Interleukin-10 and its implications in inflammation and cancer ES Acuner-Ozbabacan, BH Engin, E Guven-Maiorov, G Kuzu, ... BMC genomics 15 (4), 1-17, 2014 | 68 | 2014 |
| Network-based strategies can help mono-and poly-pharmacology drug discovery: a systems biology view H Billur Engin, A Gursoy, R Nussinov, O Keskin Current pharmaceutical design 20 (8), 1201-1207, 2014 | 50 | 2014 |
| Integrating structure to protein-protein interaction networks that drive metastasis to brain and lung in breast cancer HB Engin, E Guney, O Keskin, B Oliva, A Gursoy PloS one 8 (11), e81035, 2013 | 43 | 2013 |
| A Strategy Based on Protein-Protein Interface Motifs May Help in Identifying Drug Off-Targets BH Engin, O Keskin, R Nussinov, A Gursoy Journal of Chemical Information and Modeling, 2012 | 34 | 2012 |
| Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state TC Steed, JM Treiber, B Taha, HB Engin, H Carter, KS Patel, AM Dale, ... Journal of neuro-oncology 148 (3), 455-462, 2020 | 18 | 2020 |
| Identifying mutation specific cancer pathways using a structurally resolved protein interaction network HB Engin, M Hofree, H Carter Pacific symposium on biocomputing co-chairs, 84-95, 2014 | 10 | 2014 |
| Introducing level of detail to 3D thematic maps BH Engin | 9 | 2008 |
| Modeling of RAS complexes supports roles in cancer for less studied partners HB Engin, D Carlin, D Pratt, H Carter BMC biophysics 10 (1), 1-15, 2017 | 7 | 2017 |
| Maestro: design challenges for a group calendar B Engin, M Cetinkaya, E Ayiter, M Germen, S Balcisoy 2008 12th International Conference Information Visualisation, 491-496, 2008 | 7 | 2008 |
| Hot spots in proteineprotein interfaces: Towards drug discovery E Cukuroglu, HB Engin, A Gursoy, O Keskin Progress in Biophysics and Molecular Biology 30, 1e9, 2014 | 3 | 2014 |
| Yüksek çözünürlüklü arazi verilerinin grafik işlemcisi kullanılarak görselleştirilmesi BH Engin, E Koç, S Sümengen, S Balcısoy ODTU, 2007 | 1 | 2007 |
| ERRATUM:" Identifying Mutation Specific Cancer Pathways Using a Structurally Resolved Protein Interaction Network" HB Engin, M Hofree, H Carter PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018: Proceedings of the Pacific Symposium …, 2018 | | 2018 |
| Radiographic parameterization of the subventricular zone distance reveals associations with survival and gene expression in glioblastoma TC Steed, J Treiber, M Brandel, H Engin, K Patel, A Dale, H Carter, ... JOURNAL OF NEUROSURGERY 126 (4), A1428-A1428, 2017 | | 2017 |
| A new network attack strategy mimicking drug mechanism: Interface attack B Engin, A Gürsoy, R Nussinov, Ö Keskin F1000Research 2, 2011 | | 2011 |
| Maestro: 3D Calendar Visualizer B ENGIN, M CETINKAYA | | |
Ozlem KeskinProf of Chemical & Biological Engineering, Koc University, Istanbul TurkeyVerified email at ku.edu.tr
